Inhibition of Wee1, AKT, and CDK4 Underlies the Efficacy of the HSP90 Inhibitor XL888 in an In Vivo Model of NRAS-Mutant Melanoma

标题
Inhibition of Wee1, AKT, and CDK4 Underlies the Efficacy of the HSP90 Inhibitor XL888 in an In Vivo Model of NRAS-Mutant Melanoma
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 12, Issue 6, Pages 901-912
出版商
American Association for Cancer Research (AACR)
发表日期
2013-03-29
DOI
10.1158/1535-7163.mct-12-1003

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now